URGES-BIOSIMILAR DRUGS House SponsorsRep. Maria Antonia Berrios 1/11/2011HouseSession Sine Die Urges the Congress of the United States to help ensure that any new legislation allowing for approval of biosimilar drugs includes provisions to ensure that the public health is protected by adequate testing of biosimilar products and physician control over which treatments their patients receive, and that the legislation preserves the ability to create innovative and important new biotechnology therapies. 3/10/2009HouseFiled with the Clerk by Rep. Maria Antonia Berrios 3/11/2009HouseReferred to Rules Committee 3/16/2009HouseAssigned to Bio-Technology Committee 12/1/2009HouseRule 19(b) / Re-referred to Rules Committee 1/11/2011HouseSession Sine Die